mktcap_usd=196544
ConsensRecom=2.68
earning_yield=6.74%
growth=0.78%
dilution=-1.47%
div_ratio=56.03%
sh_payout_ratio=78.79%
margin=22.56%
cfmargin=20.11%
ratiopaid=87.74%
sratiopaid=30.13%
ratioConsens=1.15
Description
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-01-25 | 2020-01-29 | 2020-01-29 | 2020-01-29 | 2021-01-26 | 2022-02-02 | 2023-02-01 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 49386 | 43361 | 46017 | 48624 | 49898 | 52877 | 51742 | 48844 | 3270 |
| revgrowth | NaN | -13.01% | 5.95% | 5.51% | 2.59% | 5.80% | -2.17% | 0.78% | 7.43% |
| earn | 6712 | 7703 | 12611 | 11732 | 8072 | 24021 | 6955 | 11115 | 6148 |
| earnx | 6712 | 7499 | 12797 | 7142 | 8072 | 24021 | 6955 | 10457 | 6340 |
| margin | 13.59% | 17.76% | 27.41% | 24.13% | 16.18% | 45.43% | 13.44% | 22.56% | 11.37% |
| xmargin | 13.59% | 17.29% | 27.81% | 14.69% | 16.18% | 45.43% | 13.44% | 21.20% | 11.77% |
| earningyld | 3.90% | 4.05% | 6.56% | 5.05% | 3.84% | 12.10% | 3.46% | 5.57% | 3.07% |
| cfop | 11475 | 12621 | 14272 | 13625 | 13650 | 15071 | 14236 | 13564 | 1189 |
| cfinv | -3441 | -3119 | -5591 | -2226 | -13182 | 4208 | 1468 | -3126 | 5523 |
| cffin | -5314 | -7733 | -4244 | -13627 | -2208 | -16264 | -20562 | -9993 | 6891 |
| cfopmargin | 23.24% | 29.11% | 31.01% | 28.02% | 27.36% | 28.50% | 27.51% | 27.82% | 2.37% |
| cfinvmargin | -6.97% | -7.19% | -12.15% | -4.58% | -26.42% | 7.96% | 2.84% | -6.64% | 11.02% |
| cffinmargin | -10.76% | -17.83% | -9.22% | -28.03% | -4.43% | -30.76% | -39.74% | -20.11% | 13.03% |
| shares | 2616 | 2585 | 2555 | 2528 | 2503 | 2464 | 2395 | 2521 | 75.1 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 65.8 | 73.5 | 75.3 | 92.0 | 83.9 | 80.5 | 83.8 | 79.3 | 8.53 |
| dilution | NaN | -1.22% | -1.15% | -1.07% | -1.00% | -1.58% | -2.83% | -1.47% | 0.69% |
| dividend | 6475 | 6495 | 6966 | 6645 | 6987 | 7368 | 7506 | 6920 | 409 |
| sharebb | NaN | 2202 | 2190 | 2279 | 2205 | 3228 | 5644 | 2958 | 1377 |
| ltdebtbb | NaN | -5327 | 754 | 414 | -5922 | 3455 | 2741 | -648 | 4028 |
| mgtbb | NaN | -4363 | 5666 | -4289 | 1062 | -2213 | -4671 | -1468 | 4110 |
| divyld | 3.76% | 3.42% | 3.62% | 2.86% | 3.33% | 3.71% | 3.74% | 3.49% | 0.33% |
| sharebbyld | NaN | 1.22% | 1.15% | 1.07% | 1.00% | 1.58% | 2.83% | 1.47% | 0.69% |
| mgtyld | NaN | -2.29% | 2.95% | -1.84% | 0.51% | -1.12% | -2.33% | -0.69% | 2.07% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-01-25 | 2020-01-29 | 2020-01-29 | 2020-01-29 | 2021-01-26 | 2022-02-02 | 2023-02-01 | NaN | NaN |
| mktcap | 172086 | 190115 | 192332 | 232518 | 210086 | 198440 | 200764 | 199477 | 18690 |
| mktcapgrowth | NaN | 9.96% | 1.16% | 18.97% | -10.14% | -5.70% | 1.16% | 2.57% | 10.56% |
| totAsset | 130124 | 133079 | 145563 | 118370 | 127778 | 131795 | 117453 | 129166 | 9554 |
| assetgrowth | NaN | 2.25% | 8.97% | -20.68% | 7.65% | 3.10% | -11.52% | -1.71% | 11.80% |
| curAsset | 24931 | 28208 | 35563 | 29504 | 29673 | 45718 | 36910 | 32930 | 7011 |
| curAssetPct | 19.16% | 21.20% | 24.43% | 24.93% | 23.22% | 34.69% | 31.43% | 25.58% | 5.55% |
| totLiab | 55292 | 58911 | 66949 | 62896 | 71180 | 64140 | 58111 | 62497 | 5509 |
| totLiabPct | 42.49% | 44.27% | 45.99% | 53.14% | 55.71% | 48.67% | 49.48% | 48.53% | 4.74% |
| curLiab | 22209 | 23403 | 29607 | 28264 | 33059 | 30208 | 28656 | 27915 | 3833 |
| curLiabPct | 17.07% | 17.59% | 20.34% | 23.88% | 25.87% | 22.92% | 24.40% | 21.72% | 3.44% |
| ltDebt | 17897 | 23224 | 22470 | 22056 | 27978 | 24523 | 21782 | 22847 | 3046 |
| ltDebtPct | 13.75% | 17.45% | 15.44% | 18.63% | 21.90% | 18.61% | 18.55% | 17.76% | 2.61% |
| Equity | 74832 | 74168 | 78614 | 55474 | 56598 | 67655 | 59342 | 66669 | 9548 |
| EquityPct | 57.51% | 55.73% | 54.01% | 46.86% | 44.29% | 51.33% | 50.52% | 51.47% | 4.74% |
| PB | 2.30 | 2.56 | 2.45 | 4.19 | 3.71 | 2.93 | 3.38 | 3.08 | 71.01% |
Beta
len=134
mean=3.76%
sd=15.34%
alpha=-0.07%
beta=39.88%
r_sq=17.55%
lastdate=2023-03-21
firstdate=2012-12-01
logret1y=-5.68%
Financial Snapshot
CompanyName=Novartis AG
ID=1
Name=Ordinary Shares
Ticker=NOVN
ISIN=CH0012005267
RIC=NOVN.S
DisplayRIC=NOVN.S
InstrumentPI=295392
QuotePI=1032234
InstrumentPermID=8590926017
QuotePermID=55838841909
Exchange=SIX Swiss Exchange
ExchangeCode=SWF
ExchangeCountry=CHE
CoStatus=Active
CoType=Equity Issue
LastModified=2023-02-01
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=101703
SharesOut=2.120e+09
TotalFloat=2.093e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=76.2
NHIG=88.4
NLOW=73.3
PDATE=2023-03-17
VOL10DAVG=7.31
EV=191110
MKTCAP=182609
AREV=47903
AEBITD=16991
ANIAC=6439
AEPSXCLXOR=2.93
AREVPS=21.8
ABVPS=25.9
ACSHPS=8.18
ACFSHR=5.23
ADIVSHR=3.20
AGROSMGN=71.0
AROEPCT=11.0
APR2REV=3.81
APEEXCLXOR=25.9
APRICE2BK=2.93
ConsRecom=2.68
TargetPrice=87.6
ProjLTGrowthRate=6.69
ProjPE=12.5
ProjSales=48534
ProjSalesQ=11743
ProjEPS=6.09
ProjEPSQ=1.42
ProjProfit=12937
ProjDPS=3.23
quoteccy=CHF
quotefx=92.91%
exchgccy=CHF
exchgfx=92.91%
tick=None
exchg=None
Valuation
ticker=NOVN
exchg=EBS
RIC=NOVN.S
CompanyName=Novartis AG
ExchangeCode=SWF
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=eu
ccy=USD
fx=100.00%
mktcap_usd=196544
float_usd=194070
ConsensRecom=2.68
earning_yield=6.74%
growth=0.78%
dilution=-1.47%
margin=22.56%
searning_yield=3.59%
sgrowth=-6.02%
smargin=12.03%
sdilution=-0.84%
projearning_yield=7.68%
earning_excl_yield=3.77%
div_ratio=56.03%
bb_ratio=22.75%
sh_payout_ratio=78.79%
PS=3.48
price=76.2
ratio=87.74%
sratio=30.13%
sratiopaid=30.13%
ratioConsens=1.15
turnover=38.06%
cfmargin=20.11%
rdmargin=17.38%
scfmargin=8.05%
quoteccy=CHF
quotefx=92.91%
ratiopaid=87.74%
dt=2023-03-17
assetgrowth=-1.71%
dlnfx=0